Ravi Starzl, PhD: “If you’re constantly focused on trying to escalate the war of destruction, I think that the bacteria will always win that war. They just have too many countermeasures available to them and our rate of developing new antibiotics is far slower than their rate of developing countermeasures.”
We will eventually win the war against coronavirus disease 2019 (COVID-19), now that the vaccines have entered the fray. Those miracles of modern medicine, along with the low-tech infection prevention methods—hand hygiene, social distancing, masking—will eventually lead to the herd immunity that will then eventually lead us back to our old lives, or some semblance of our old lives, at least so say the experts. One of the important lessons of the pandemic, says Ravi Starzl, PhD, an adjunct professor at Carnegie Mellon University and the CEO of a company called BioPix, is that pandemics can indeed happen and can indeed disrupt the entire world. COVID-19 is caused by a virus. The danger that Starzl worries about are the Superbugs, which are for the most part bacterial and which can shrug off any antibiotics that are thrown at it. (BioPix’s stated mission is to combat Superbugs. Just to name one: methicillin-resistant Staphylococcus aureus--MRSA.) Starlz explains to Infection Control Today® just what makes the Superbugs such a threat; one that will be with us long after COVID-19 (hopefully) goes away. Medicine cannot hope to win a war with Superbugs, Starlz contends. These bacteria can rely on billions of years of evolutionary development in which they’ve overcome some variant of man-made antibiotics. “By the year 2050, we will have very few options indeed, against antimicrobial resistant bacteria, at which point basic things like surgery, simple broken-bone mending, will become very complicated,” Starlz tells ICT®. “The one lesson that we can learn from COVID-19 is to not take pandemics lightly. They can occur, and they can totally change the world we live in. And when you’re looking at something that jeopardizes the entire foundation of modern medicine, like antimicrobial resistance, and the mechanisms that bacteria are using to share that information and spread antimicrobial resistance amongst their populations, we really need to take it extremely seriously. Because it’s far worse than COVID-19.” Starlz says that the way to defeat Superbugs is by keeping “them out of your microbiome in the first place by managing the niches that they could occupy by replacing those niches with non-antimicrobial resistant cousins that can exclude them from your microbiome.”
Top 7 Infection Control Today Articles of 2024: Insights and Innovations
December 30th 2024From advanced sterilization methods to combating antimicrobial resistance, Infection Control Today’s top articles of 2024 delivered actionable strategies for safer healthcare environments and improved patient outcomes.
Revolutionizing Infection Prevention: How Fewer Hand Hygiene Observations Can Boost Patient Safety
December 23rd 2024Discover how reducing hand hygiene observations from 200 to 50 per unit monthly can optimize infection preventionists' time, enhance safety culture, and improve patient outcomes.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.